Sign in
4/A

Changes in Ownership

ProQR Therapeutics N.V. Filed Acc 0001104659-26-079319

Options or other derivatives

  • Director acquired 14,595 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hinsch Gylvin Lykke Director 2026-06-02 Grant or award · Share Option (Right to Buy) +14,595 14,595 D
Loading xslF345X06/tm2619428-2_4aseq1.xml…